Full Text
Phase I/II Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukemia

Abstract

Authors

RA Vreman JW Geenen WG Goettsch AM Hovels HG Leufkens MJ Al

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×